Becker's Healthcare April 12, 2023
Noah Schwartz

Rochester, Minn.-based Mayo Clinic is partnering with biotech company Naveris to launch a clinical trial of the company’s precision medicine blood test for tumor tissue DNA, NavDx.

Naveris aims for NavDx to improve treatment selection in patients with HPV-based head and neck cancers. NavDx analyzes tumor-derived DNA from patients’ blood samples to monitor for residual molecular disease, according to an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Health System / Hospital, Partnerships, Pharma / Biotech, Precision Medicine, Provider, Trends
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
Will Walgreens’ store closures disrupt its clinical trial aims?
Veeva Commercial Summit: Increased investment in medical affairs by pharma companies
Non-binding Guidance: Clinical Trial Diversity in Focus
NIH algorithm matches patients to clinical trials

Share This Article